BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) to Release Early Efficacy Data from Combination Study at AACR Annual Meeting

March 29, 2019 10:21:18
  • BriaCell has achieved proof of concept for its lead cellular immunotherapy product, Bria-IMT, which targets advanced breast cancer
  • Combination study pairing KEYTRUDA with Bria-IMT is ongoing, with initial efficacy data for the first six patients to be released at AACR Annual Meeting
  • BriaCell has closed the first tranche of a previously announced non-brokered private placement, raising gross proceeds of C$750,000

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a clinical stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, will present an analysis of the initial efficacy data compiled during a combination study that pairs Bria-IMT, the company’s lead cellular immunotherapy candidate, with pembrolizumab (KEYTRUDA, manufactured by Merck & Co. Inc.) in advanced breast cancer. Data is now being finalized and will be shared via press release and in conjunction with BriaCell’s poster presentation at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Georgia, on April 3 (

“The early efficacy data of the first six patients in our Phase I/IIa study of Bria-IMT with KEYTRUDA represents an important milestone for BriaCell as a rapidly advancing company with an…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to BCTXF are available in the company’s newsroom at

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office